October 31, 2016

NRG-GY001: Closure effective November 30, 2015 (posted to CTSU)

RTOG 0825: Amendment 8, version date: October 3, 2016; also available on the CTSU website

NRG-CC001: Amendment 1, version date: August 17, 2016 has been approved by Health Canada. Sites in Canada can find the NOL and required TPD forms on the NRG Oncology Website

RTOG 0631: Amendment 10, version date: September 23, 2016

NSABP B-55/BIG 6-13: OlympiA Newsletter, 11th Issue (posted to CTSU)

NRG-GI002: A memorandum regarding a correction in the TNT Plus Sites ITGA Manual and the corrected manual are posted to CTSU

GOG-0265: A memorandum regarding Additional Data Collection and Study Documents is posted to the GOG legacy website

The VTOC Webinar Training Series schedule and registration is available for NRG Oncology Research Associates working on RTOG 0924, RTOG 0920, NRG-HN001, NRG-HN002, and NRG-CC003. Space is limited so register now and reserve your seat. The next webinar training is scheduled for November 16, 2016.

Safety updates have been issued for NSABP legacy studies. For details, please see the NSABP E-mail Distributions page and the CTSU website.

Want to be highlighted in the next NRG Oncology Newsletter for a recent accomplishment in cancer research?
If you were recently recognized or have won an award for your contributions in the field of cancer research, our Communications Committee would like to feature you in the “In the News” section of our upcoming NRG Oncology Newsletter. Please email info@nrgoncology.org and put “In the News” in the subject line. All submissions are due by November 18, 2016.

NRG Oncology is pleased to report the scientific articles and abstracts that have appeared or have been presented during the previous week. This publications report includes links, when available, to the article, PubMed abstract, or association abstract.


Gilbert MR, Pugh SL, Aldape K, Sorensen AG, Mikkelsen T, Penas-Prado M, Bokstein F, Kwok Y, Lee RJ, Mehta M. NRG oncology RTOG 0625: a randomized phase II trial of bevacizumab with either irinotecan or dose-dense temozolomide in recurrent glioblastoma. J Neurooncol. 2016 Oct 21. PubMed PMID: 27770279. Read more

Please note the following upcoming meeting and abstract submission deadline dates.

Upcoming Meetings
Radiological Society of North America (RSNA); Nov 27-Dec 2, 2016; Chicago, IL
Society for Neuro-Oncology (SNO); Nov 17-20, 2016; Scottsdale, AZ
San Antonio Breast Cancer Symposium (SABCS); Dec 6-10, 2016; San Antonio, TX

Upcoming abstract submission deadlines
American Association for Cancer Research (AACR); Apr 1-5, 2017; Washington DC; due to publications committee Nov 3, 2016; meeting abstracts submission deadline Nov 17, 2016

American Association of Medical Dosimetrists (AAMD); Jun 10-15, 2017; Indianapolis, IN; meeting abstracts submission deadline Oct 31, 2016; deadline for posters Mar 15, 2017

American Radium Society (ARS); May 6-9, 2017; Colorado Springs, CO; due to publications committee Nov 4, 2016; meeting abstracts submission deadline Nov 18, 2016

American Society of Breast Surgeons (ASBS); Apr 26-27, 2017; Las Vegas, NV; meeting abstracts submission deadline Nov 8, 2016

American Society of Colon and Rectal Surgeons (ASCRS); Jun 10-14, 2017; Seattle, WA; due to publications committee Nov 15, 2016; meeting abstracts submission deadline Nov 29, 2016

American Head & Neck Society (AHNS); Apr 26-27, 2017; San Diego, CA; meeting abstracts submission deadline Nov 9, 2016

American Urology Association (AUA); May 12-16, 2017; Boston, MA; due to publications committee Nov 2, 2016; meeting abstracts submission deadline Nov 14, 2016

Digestive Disease Week (DDW); May 6-9, 2017; Chicago, IL; due to publications committee Nov 17, 2016; meeting abstracts submission deadline Dec 1, 2016

Society for Clinical Trials (SCT); May 7-10, 2017; Liverpool, UK; meeting abstracts submission deadline Nov 10, 2016

Society of Gynecologic Oncology (SGO); Mar 12-15, 2017; National Harbor, MD; meeting abstracts submission deadline Dec 31, 2016 Global session; Dec 5-Jan 8, 2017 LBA

St. Gallen Breast Cancer Conference; Mar 15-18, 2017; Vienna, Austria; due to publications committee Dec 1, 2016; meeting abstracts submission deadline Dec 15, 2016

NRG Oncology is proud to be an active participant of #CancerMoonShot.

View this email in your browser
You are receiving this email because of your relationship with NRG Oncology. Please reconfirm your interest in receiving emails from us. If you do not wish to receive any more emails, you can unsubscribe here.

Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103

Update Profile/Email Address